Distributors

Our current projects involve the discovery and validation of biomarkers for different pathologies. Relative to our focus is our development of an optoelectronic biochip for the simultaneous determination of tumor molecular markers. We are further involved in the discovery of different applications for our platform technology Combinatorial Proteomic®. Additional information regarding programs that may fall within our focus are welcomed, so please contact us at info@xeptagen.com